Close
ACHEMA MIDDLE EAST 2026

Pharma Industry Groups Criticise Proposed EU Drug Regulation

The EU's drug regulations can get a major makeover soon. In a set of proposals, the European Commission looks to address numerous shortfalls troubling...

Phase I Trial of The South Korean DuoChol Vaccine In Sweden

The South Korea-based International Vaccine Institute- IVI has gone ahead with the clinical manufacturing of DuoChol, a new low-cost oral vaccine for cholera in...

EU Drug Manufacturing Law Changes Disappoint Manufacturers

The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws. The changes have...

AMR Is The Main Focus of New Research Consortium In World

Global research consortium is being set up to address the international impact of antimicrobial resistance (AMR). Significantly, the Centres for Antimicrobial Optimisation Network- CAMO-Net...

Gene Silencing Alzheimers Drug, A World First, Shows Promise

UK scientists have gone on to conduct the first ever trial of a new drug for Alzheimer’s that is able to safely as well...

Australia Falling Short In Biotech Research Funding – Study

Research co-led by the University of Queensland has found that Australia is falling short of similar countries when it comes to funding basic research,...

Viral Infections Curbed By Gene Scissors In Human Cells

It is still difficult to get to the bottom of viral illnesses. Although isolated medicines exist that block virus multiplication in human cells, they...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...